Finance and markets: business, quotes, gold, energy and releases.
Delcath Systems shares climbed to a 52-week high Monday after the interventional oncology company reported third-quarter results above analysts’ forecasts and lifted its full-year revenue outlook. The stock rose 28% to $19.12 late in the morning, after reaching $19.35 earlier in the session.
Delcath reported quarterly earnings of 17 cents a share on revenue of $35.1 million. Analysts polled by FactSet had expected the Queensbury, N.Y.-based company to post a loss of 9 cents a share on revenue of $26 million.
The company now expects full-year revenue of $115 million to $117 million, up from its previous forecast of $104 million to $108 million. Analysts had projected revenue of $106.4 million.
When reusing this material a link to Money Talk is required.
Comments (0)
No comments yet. Be the first!